Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism ABL1 inhibitors(ABL proto-oncogene 1 inhibitors), BCR inhibitors(BCR activator of RhoGEF and GTPase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Discovery | - | 19 May 2023 | |
Diabetes Mellitus | Discovery | - | 19 May 2023 | |
Inflammation | Discovery | - | 19 May 2023 | |
Nervous System Diseases | Discovery | - | 19 May 2023 | |
Pulmonary Fibrosis | Discovery | - | 19 May 2023 | |
Virus Diseases | Discovery | - | 19 May 2023 |